Keloids are raised overgrowths of scar tissue that can form at the site of a wound or injury. While there is no definitive cure for keloids, various treatment options are available to manage symptoms and reduce their appearance. Companies involved in keloid treatment may offer a range of solutions, including medical interventions, topical treatments, and surgical procedures.
Avita Medical RECELL System, using autologous cell suspensions for burn and wound healing, received Japanese regulatory approval, expanding its potential reach for keloid treatment.
Revita Corporation topical gel containing hyaluronic acid and palmitoyl tripeptide-5 demonstrated positive results in a Phase 2 trial for preventing keloid scarring after earlobe piercing, opening doors for non-invasive management.
Xiamen Sinocare Medical Science & Technology Co. Phase 3 trial assessing the efficacy of a silicone gel sheet for preventing keloid recurrence after surgical wound closure is ongoing, potentially adding another tool to the arsenal.
Sensus Healthcare company focuses on silicone gel sheet technologies for scar management, actively pursuing clinical research and expanding their product portfolio to address diverse keloid treatment needs.
Mylan N.V. pharmaceutical giant acquired several keloid treatment products, including imiquimod cream, showcasing increased interest in the market's potential.
List of Keloid Treatment Key Companies in the Market
Keloid Treatment Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)